We are monitoring the impact of COVID-19 on Europe Drug Delivery Devices Market Get in touch with us for detailed analysis Know More
Pulished Date August, 2019
ID: 2253
Share on
Share on

Europe Drug Delivery Devices Market Research Report – Segmented By Route Of Administration, By Facility Of Use, By Country - Industry Analysis, Size, Share, Growth, Trends, Forecast (2019-2024)

Pulished: August, 2019
ID: 2253
Pages: 140

Europe Drug Delivery Devices Market Size & Growth (2019-2024)

European Drug Delivery Devices was worth USD 321.04 Million in the year 2019 and It is expected to reach USD 427.6 Million by 2024 growing at a CAGR of 5.9% during the forecast period 2019-2024.

This market is based upon unending infections, for example, cardiovascular illnesses, diabetes and disease, developing the interest for self-organization and home drug delivery devices, patent expiries of certain blockbuster drugs and developing spotlight on pediatric and geriatric patients. Oral Drug Delivery possessed the biggest section of the overall industry in Europe in 2012, while it is the fastest-growing section of the European Drug Delivery Devices.

Some of the important drivers of the Europe drug delivery devices market are increased investment by pharmaceutical companies and medical device companies in chronic illness research and development. In addition, factors such as the growth of biosimilars, innovation in drug development, and advancements in technology, new product launches, and reduction in pain level are the other factors driving the growth of the market. Europe has a large pool of patients undergoing different conditions of chronic illness. Europe is heavily impacted by non-communicable diseases including cardiovascular diseases, diabetes, cancer, mental disorders, and chronic respiratory diseases. This also adds to the growth of the drug delivery devices market in Europe.

On the other side, regulatory recalls by European suppliers of drug delivery systems are likely to have a negative effect on the development of the industry to some degree and will hamper the growth of the region’s market. 

Throughout the forecast period, some of the future growth prospects for this sector are that the design of drug delivery devices is to cater to the growing occurrence of infectious diseases in Europe which is anticipated to provide growth opportunities for the region's market players. Also, the growing technological advancements and introduction and development of controlled systems like Novel drug delivery systems in Europe will help the market with numerous opportunities.

The drivers for the Europe Drug delivery market increase in the advancement of technology, an increase in the prevalence of chronic diseases, a rise in individual therapy, a need for control on drug release and, Increase in the awareness about drug metabolism among people. Few restraints which account for the decline in the market are fear among individuals regarding infections and injuries during the operation, strict regulatory framework, and rise in the cost of development.

Europe Drug Delivery Devices Market segmented and sub-segmented into the following categories.

  • By Route of Administration: Oral Drug Delivery, Pulmonary Drug Delivery, Injectable Drug Delivery, Ocular Drug Delivery, Nasal Drug Delivery, Topical Drug Delivery, Implantable Drug Delivery, and Tran mucosal Drug Delivery.
  • By End-User: Hospitals, Ambulatory Surgical Centers, Home Care settings, Diagnostic Centers.
  • By Region: UK, France, Spain, Germany, Italy, Russia, Sweden, Denmark, Switzerland, Netherlands, Turkey, Czech Republic and Rest of Europe

Among the mentioned countries, France is anticipated to be the fastest-growing market in Europe. Among the most important drivers of this demand is the growing prevalence of target conditions like diabetes in major economies like the UK and Germany. High growth opportunities in major European markets will support the industry's healthy growth in the upcoming years. UK, Germany and the rest of Europe are also projected to grow at a substantial rate and will possibly contribute a significant share of the market in the future. Strategic and innovative decisions related to Research and Development, production units, organizing the overall investment, periodic mergers, and acquisitions, collaboration deals are the factors that can alter the region's market dynamics.

Some of the Prominent Companies leading the Europe Drug Delivery Devices Market Profiled in the Report are Bend Research, Endocyte, Microchips Inc., Pearl Therapeutics Inc., Presage Bioscience, UCB Group, Genentech Inc., Polymer Factory, Alkermes Inc., BIND Biosciences Inc. and QLT Inc.

1.Introduction                                  

                1.1 Market Definition                    

                1.2 Study Deliverables                  

                1.3 Base Currency, Base Year and Forecast Periods                          

                1.4 General Study Assumptions                

2. Research Methodology                                           

                2.1 Introduction                               

                2.2 Research Phases                      

                                2.2.1 Secondary Research           

                                2.2.2 Primary Research 

                                2.2.3 Econometric Modelling      

                                2.2.4 Expert Validation  

                2.3 Analysis Design                         

                2.4 Study Timeline                          

3. Overview                                       

                3.1 Executive Summary                

                3.2 Key Inferences                         

                3.3 Epidemology                              

4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)                                    

                4.1 Market Drivers                          

                4.2 Market Restraints                    

                4.3 Key Challenges                         

                4.4 Current Opportunities in the Market                              

5. Market Segmentation                                              

                5.1 Route of administration                        

                                5.1.1 Introduction           

                                5.1.2 Oral Drug Delivery

                                5.1.3 Pulmonary Drug Delivery  

                                5.1.4 Inject able Drug Delivery   

                                5.1.5 Ocular Drug Delivery           

                                5.1.6 Nasal Drug Delivery             

                                5.1.7 Topical Drug Delivery          

                                5.1.8 Implantable Drug Delivery                

                                5.1.9 Tran mucosal Drug Delivery             

                                5.1.10  Y-o-Y Growth Analysis, By Route of administration            

                                5.1.11  Market Attractiveness Analysis, By Route of administration          

                                5.1.12  Market Share Analysis, By Route of administration            

                5.2 Facility of use                             

                                5.2.1 Introduction           

                                5.2.2 Hospitals  

                                5.2.3 Ambulatory Surgical Centers           

                                5.2.4 Home care settings             

                                5.2.5 Diagnostic Centers               

                                5.2.6 Others      

                                5.2.7 Y-o-Y Growth Analysis, By Facility of use    

                                5.2.8 Market Attractiveness Analysis, By Facility of use  

                                5.2.9 Market Share Analysis, By Facility of use    

6. Geographical Analysis                                              

                6.1 Introduction                               

                                6.1.1 Regional Trends    

                                6.1.2 Impact Analysis     

                                6.1.3 Y-o-Y Growth Analysis        

                                                6.1.3.1 By Geographical Area

                                                6.1.3.2 Route of administration

                                                6.1.3.3 By Facility of use

                                6.1.4  Market Attractiveness Analysis     

                                                6.1.4.1 By Geographical Area

                                                6.1.4.2 By Route of administration

                                                6.1.4.3 By Facility of use

                                6.1.5  Market Share Analysis      

                                                6.1.5.1 By Geographical Area

                                                6.1.5.2 By Route of administration

                                                6.1.5.3 By Facility of use

                6.2 U.K                 

                6.3 Spain                             

                6.4 Germany                     

                6.5 Italy                               

                6.6 France                          

7.Strategic Analysis                                        

                7.1 PESTLE analysis                         

                                7.1.1 Political     

                                7.1.2 Economic 

                                7.1.3 Social         

                                7.1.4 Technological         

                                7.1.5 Legal          

                                7.1.6 Environmental       

                7.2 Porter’s Five analysis                              

                                7.2.1 Bargaining Power of Suppliers        

                                7.2.2 Bargaining Power of Consumers    

                                7.2.3 Threat of New Entrants     

                                7.2.4 Threat of Substitute Products and Services              

                                7.2.5 Competitive Rivalry within the Industry     

8.Market Leaders' Analysis                                         

                8.1 Bend Research                          

                                8.1.1 Overview 

                                8.1.2 Product Analysis   

                                8.1.3 Financial analysis  

                                8.1.4 Recent Developments       

                                8.1.5 SWOT analysis       

                                8.1.6 Analyst View          

                8.2 Endocyte                     

                8.3 MicroCHIPS Inc                         

                8.4 Pearl Therapeutics Inc                           

                8.5 Presage Bioscience                 

                8.6 UCB Group                 

                8.7 Genentech Inc                          

                8.8 Polymer Factory                       

                8.9 Alkermes Inc                              

                8.10 BIND Biosciences Inc                            

                8.11 QLT Inc                       

9.Competitive Landscape                                            

                9.1 Market share analysis                            

                9.2 Merger and Acquisition Analysis                       

                9.3 Agreements, collaborations and Joint Ventures                         

                9.4 New Product Launches                         

10.Market Outlook and Investment Opportunities                                          

Appendix                                           

                a) List of Tables                

                b) List of Figures                              

  • Regional and country-level analysis and forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped
  • Segment-level analysis in terms of technology, component, and type along with market size forecasts and estimations to detect key areas of industry growth in detail
  • Identification of key drivers, restraints, opportunities, and challenges (DROC) in the market and their impact on shifting market dynamics
  • Study of the effect of exogenous and endogenous factors that affect the global market; which includes broadly demographic, economics, and political, among other macro-environmental factors presented in an extensive PESTLE Analysis
  • Study the micro environment factors that determine the overall profitability of an Industry, using Porter’s five forces analysis for analysing the level of competition and business strategy development
  • A comprehensive list of key market players along with their product portfolio, current strategic interests, key financial information, legal issues, SWOT analysis and analyst overview to study and sustain the market environment
  • Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies
  • An executive summary, abridging the entire report in such a way that decision-making personnel can rapidly become acquainted with background information, concise analysis and main conclusions
  • Expertly devised analyst overview along with Investment opportunities to provide both individuals and organisations a strong financial foothold in the market
  1. Europe Drug Delivery Devices Market By Route of administration, From 2019-2024 ( USD Million )
  2. Europe Oral Drug Delivery Market By Region, From 2019-2024 ( USD Million )
  3. Europe Pulmonary Drug Delivery Market By Region, From 2019-2024 ( USD Million )
  4. Europe Injectable Drug Delivery Market By Region, From 2019-2024 ( USD Million )
  5. Europe Ocular Drug Delivery Market By Region, From 2019-2024 ( USD Million )
  6. Europe Nasal Drug Delivery Market By Region, From 2019-2024 ( USD Million )
  7. Europe Topical Drug Delivery Market By Region, From 2019-2024 ( USD Million )
  8. Europe Implantable Drug Delivery Market By Region, From 2019-2024 ( USD Million )
  9. Europe Tran mucosal Drug Delivery Market By Region, From 2019-2024 ( USD Million )
  10. Europe Drug Delivery Devices Market By Facility of use, From 2019-2024 ( USD Million )
  11. Europe Hospitals Market By Region, From 2019-2024 ( USD Million )
  12. Europe Ambulatory Surgical Centers Market By Region, From 2019-2024 ( USD Million )
  13. Europe Home Care settings Market By Region, From 2019-2024 ( USD Million )
  14. Europe Diagnostic Centers Market By Region, From 2019-2024 ( USD Million )
  15. Europe Others Market By Region, From 2019-2024 ( USD Million )
  16. U.K. Drug Delivery Devices Market By Route of administration , From 2019-2024 ( USD Million )
  17. U.K. Drug Delivery Devices Market By Facility of use, From 2019-2024 ( USD Million )
  18. Germany Drug Delivery Devices Market By Route of administration , From 2019-2024 ( USD Million )
  19. Germany Drug Delivery Devices Market By Facility of use, From 2019-2024 ( USD Million )
  20. France Drug Delivery Devices Market By Route of administration , From 2019-2024 ( USD Million )
  21. France Drug Delivery Devices Market By Facility of use, From 2019-2024 ( USD Million )
  22. Italy Drug Delivery Devices Market By Route of administration , From 2019-2024 ( USD Million )
  23. Italy Drug Delivery Devices Market By Facility of use, From 2019-2024 ( USD Million )
  24. Spain Drug Delivery Devices Market By Route of administration , From 2019-2024 ( USD Million )
  25. Spain Drug Delivery Devices Market By Facility of use, From 2019-2024 ( USD Million )

 

Please wait. . . . Your request is being processed

Related Reports

LICENCE TYPE

$ 1234 3335

Clients
clients
clients
clients
clients
clients
clients
Click for Request Sample